slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 96,741
Current window 84,631-84,660
Pages 3,225
Rows per page 30
Component
84,631-84,660 of 96,741
03
The background contains scattered DNA base letters (A, T, C, G), suggesting a biotech or healthcare context.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
04
The chart uses a gradient arrow to emphasize the scale of 12.2M participants compared to other biobanks.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
11
The slide highlights the scale of the 23andMe database and its application across three business pillars.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
15
The slide highlights the breadth of genetic reporting and emphasizes FDA authorizations.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
18
The slide features a background pattern of DNA base pairs (A, T, C, G) and a central circle with the number 3.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
25
The slide uses a gradient background and visual representations of mobile app screens to illustrate the integration of genetic insights into primary care.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
26
The slide features a gradient background with scattered DNA base letters (A, T, C, G) and a central circle containing the number 4.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
44
Uses heatmaps to visualize genetic associations with various disease phenotypes.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
55
The slide highlights a 34% YoY increase in Therapeutics R&D spending.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
38
The slide uses a high-quality photo of a researcher to emphasize R&D focus.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
46
Uses a process flow to illustrate the 'playbook' for growth.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
47
Uses a process-flow diagram to illustrate the business model components.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
56
3M | Investor Day Presentation Deck | 94 slides3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
63
Includes a specific guidance metric for organic sales growth.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
73
The table uses color-coding (green/red) to highlight performance against targets. The slide emphasizes a culture of addressing 'reds' for continuous improvement.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
75
The slide uses a numbered list format to categorize strategic priorities.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
82
The slide uses a numbered list to categorize strategic priorities based on market strength and ownership capability.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
11
The chart is a stacked bar representation of milestone payments by stage.AbCellera | Results Presentation Deck | 21 slides · AbCellera
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
20
Includes patient photo and clinical data table comparing normal ranges to patient baseline.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
21
The chart is a box plot showing arginine levels over time, with reference lines for normal and target ranges.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Pegzilarginase Program OverviewLoop · Jobs To Be Done1 hit
24
Clinical trial safety data presentation.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Loop · Jobs To Be Done1 hit
25
The chart uses box plots to show distribution, with specific clinical guideline and normal range thresholds marked.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Loop · Jobs To Be Done1 hit
26
The slide highlights the efficacy of pegzilarginase in a clinical setting.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Loop · Jobs To Be Done1 hit
27
Includes MCID thresholds for GMFM-E (GMFCS I and II).Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
29
Includes patient photos as visual evidence of mobility improvement.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
04
The slide uses a background image of sheep to reinforce the brand's natural materials focus.Allbirds | Investor Presentation Deck | 30 slides · Allbirds
Pitch deck Investor relations 1 hit
29
The slide outlines the firm's ESG/DEI framework, highlighting internal culture, investment strategy, and governance structures.AlTi | SPAC Presentation Deck | 33 slides · Alvarium Tiedemann Capital
Pitch deck Investment bank 1 hit
28
PoM = Proof of Mechanism; ALSP = Adult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
40
The slide uses box plots to compare control vs VG-3440 across six different biological metrics.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank 1 hit
46
The slide presents histological images and quantitative dot plots comparing Trem2 wild-type, heterozygous, and knockout mice.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank 1 hit